Global Vinorelbine Market Growth 2020-2025
According to this study, over the next five years the Vinorelbine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vinorelbine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Vinorelbine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Vinorelbine, covering the supply chain analysis, impact assessment to the Vinorelbine market size growth rate in several scenarios, and the measures to be undertaken by Vinorelbine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
Injection
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Breast Cancer
Non-small Cell Lung Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pierre Fabre Pharmaceuticals, Inc.
Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
TEVA Pharms
West-Ward Pharmaceuticals Corp.
Fresenius Kabi
Hospira, Inc.
Mylan
EBEWE Pharma (Sandoz A Novartis Division)
Dr. Reddy's Laboratories
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Shanxi Powerdone Pharmaceutics Co., Ltd.
Luoxin Pharmaceutical Group Co., Ltd.
Nanjing Cuccess Pharmaceutical Co., Ltd
Beijing SL Pharm
Sinopharm A-Think Pharmaceutical Co., Ltd.
Shenzhen Main Luck Pharmaceuticals Inc.
Qilu Pharmaceutical (Hainan) Co., Ltd.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Vinorelbine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Vinorelbine market by identifying its various subsegments.
Focuses on the key global Vinorelbine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vinorelbine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vinorelbine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vinorelbine Consumption 2015-2025
2.1.2 Vinorelbine Consumption CAGR by Region
2.2 Vinorelbine Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Vinorelbine Consumption by Type
2.3.1 Global Vinorelbine Consumption Market Share by Type (2015-2020)
2.3.2 Global Vinorelbine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vinorelbine Sale Price by Type (2015-2020)
2.4 Vinorelbine Segment by Application
2.4.1 Breast Cancer
2.4.2 Non-small Cell Lung Cancer
2.4.3 Other
2.5 Vinorelbine Consumption by Application
2.5.1 Global Vinorelbine Consumption Market Share by Type (2015-2020)
2.5.2 Global Vinorelbine Value and Market Share by Type (2015-2020)
2.5.3 Global Vinorelbine Sale Price by Type (2015-2020)
3 Global Vinorelbine by Company
3.1 Global Vinorelbine Sales Market Share by Company
3.1.1 Global Vinorelbine Sales by Company (2018-2020)
3.1.2 Global Vinorelbine Sales Market Share by Company (2018-2020)
3.2 Global Vinorelbine Revenue Market Share by Company
3.2.1 Global Vinorelbine Revenue by Company (2018-2020)
3.2.2 Global Vinorelbine Revenue Market Share by Company (2018-2020)
3.3 Global Vinorelbine Sale Price by Company
3.4 Global Vinorelbine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vinorelbine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vinorelbine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vinorelbine by Regions
4.1 Vinorelbine by Regions
4.2 Americas Vinorelbine Consumption Growth
4.3 APAC Vinorelbine Consumption Growth
4.4 Europe Vinorelbine Consumption Growth
4.5 Middle East & Africa Vinorelbine Consumption Growth
5 Americas
5.1 Americas Vinorelbine Consumption by Countries
5.1.1 Americas Vinorelbine Consumption by Countries (2015-2020)
5.1.2 Americas Vinorelbine Value by Countries (2015-2020)
5.2 Americas Vinorelbine Consumption by Type
5.3 Americas Vinorelbine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Vinorelbine Consumption by Regions
6.1.1 APAC Vinorelbine Consumption by Regions (2015-2020)
6.1.2 APAC Vinorelbine Value by Regions (2015-2020)
6.2 APAC Vinorelbine Consumption by Type
6.3 APAC Vinorelbine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Vinorelbine by Countries
7.1.1 Europe Vinorelbine Consumption by Countries (2015-2020)
7.1.2 Europe Vinorelbine Value by Countries (2015-2020)
7.2 Europe Vinorelbine Consumption by Type
7.3 Europe Vinorelbine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Vinorelbine by Countries
8.1.1 Middle East & Africa Vinorelbine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vinorelbine Value by Countries (2015-2020)
8.2 Middle East & Africa Vinorelbine Consumption by Type
8.3 Middle East & Africa Vinorelbine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vinorelbine Distributors
10.3 Vinorelbine Customer
11 Global Vinorelbine Market Forecast
11.1 Global Vinorelbine Consumption Forecast (2021-2025)
11.2 Global Vinorelbine Forecast by Regions
11.2.1 Global Vinorelbine Forecast by Regions (2021-2025)
11.2.2 Global Vinorelbine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vinorelbine Forecast by Type
11.8 Global Vinorelbine Forecast by Application
12 Key Players Analysis
12.1 Pierre Fabre Pharmaceuticals, Inc.
12.1.1 Company Information
12.1.2 Vinorelbine Product Offered
12.1.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pierre Fabre Pharmaceuticals, Inc. Latest Developments
12.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
12.2.1 Company Information
12.2.2 Vinorelbine Product Offered
12.2.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Latest Developments
12.3 TEVA Pharms
12.3.1 Company Information
12.3.2 Vinorelbine Product Offered
12.3.3 TEVA Pharms Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 TEVA Pharms Latest Developments
12.4 West-Ward Pharmaceuticals Corp.
12.4.1 Company Information
12.4.2 Vinorelbine Product Offered
12.4.3 West-Ward Pharmaceuticals Corp. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 West-Ward Pharmaceuticals Corp. Latest Developments
12.5 Fresenius Kabi
12.5.1 Company Information
12.5.2 Vinorelbine Product Offered
12.5.3 Fresenius Kabi Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Fresenius Kabi Latest Developments
12.6 Hospira, Inc.
12.6.1 Company Information
12.6.2 Vinorelbine Product Offered
12.6.3 Hospira, Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Hospira, Inc. Latest Developments
12.7 Mylan
12.7.1 Company Information
12.7.2 Vinorelbine Product Offered
12.7.3 Mylan Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Mylan Latest Developments
12.8 EBEWE Pharma (Sandoz A Novartis Division)
12.8.1 Company Information
12.8.2 Vinorelbine Product Offered
12.8.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 EBEWE Pharma (Sandoz A Novartis Division) Latest Developments
12.9 Dr. Reddy's Laboratories
12.9.1 Company Information
12.9.2 Vinorelbine Product Offered
12.9.3 Dr. Reddy's Laboratories Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Dr. Reddy's Laboratories Latest Developments
12.10 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
12.10.1 Company Information
12.10.2 Vinorelbine Product Offered
12.10.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
12.11 Shanxi Powerdone Pharmaceutics Co., Ltd.
12.11.1 Company Information
12.11.2 Vinorelbine Product Offered
12.11.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shanxi Powerdone Pharmaceutics Co., Ltd. Latest Developments
12.12 Luoxin Pharmaceutical Group Co., Ltd.
12.12.1 Company Information
12.12.2 Vinorelbine Product Offered
12.12.3 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Luoxin Pharmaceutical Group Co., Ltd. Latest Developments
12.13 Nanjing Cuccess Pharmaceutical Co., Ltd
12.13.1 Company Information
12.13.2 Vinorelbine Product Offered
12.13.3 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Nanjing Cuccess Pharmaceutical Co., Ltd Latest Developments
12.14 Beijing SL Pharm
12.14.1 Company Information
12.14.2 Vinorelbine Product Offered
12.14.3 Beijing SL Pharm Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Beijing SL Pharm Latest Developments
12.15 Sinopharm A-Think Pharmaceutical Co., Ltd.
12.15.1 Company Information
12.15.2 Vinorelbine Product Offered
12.15.3 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Sinopharm A-Think Pharmaceutical Co., Ltd. Latest Developments
12.16 Shenzhen Main Luck Pharmaceuticals Inc.
12.16.1 Company Information
12.16.2 Vinorelbine Product Offered
12.16.3 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Shenzhen Main Luck Pharmaceuticals Inc. Latest Developments
12.17 Qilu Pharmaceutical (Hainan) Co., Ltd.
12.17.1 Company Information
12.17.2 Vinorelbine Product Offered
12.17.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Vinorelbine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of Injection
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Vinorelbine Consumption Market Share by Type (2015-2020)
Table 8. Global Vinorelbine Revenue by Type (2015-2020) ($ million)
Table 9. Global Vinorelbine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Vinorelbine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Vinorelbine Consumption Market Share by Application (2015-2020)
Table 13. Global Vinorelbine Value by Application (2015-2020)
Table 14. Global Vinorelbine Value Market Share by Application (2015-2020)
Table 15. Global Vinorelbine Sale Price by Application (2015-2020)
Table 16. Global Vinorelbine Sales by Company (2017-2019) (MT)
Table 17. Global Vinorelbine Sales Market Share by Company (2017-2019)
Table 18. Global Vinorelbine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Vinorelbine Revenue Market Share by Company (2017-2019)
Table 20. Global Vinorelbine Sale Price by Company (2017-2019)
Table 21. Global Vinorelbine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Vinorelbine Products Offered
Table 23. Vinorelbine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Vinorelbine Consumption by Regions 2015-2020 (MT)
Table 25. Global Vinorelbine Consumption Market Share by Regions 2015-2020
Table 26. Global Vinorelbine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Vinorelbine Value Market Share by Regions 2015-2020
Table 28. Americas Vinorelbine Consumption by Countries (2015-2020) (MT)
Table 29. Americas Vinorelbine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Vinorelbine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Vinorelbine Value Market Share by Countries (2015-2020)
Table 32. Americas Vinorelbine Consumption by Type (2015-2020) (MT)
Table 33. Americas Vinorelbine Consumption Market Share by Type (2015-2020)
Table 34. Americas Vinorelbine Consumption by Application (2015-2020) (MT)
Table 35. Americas Vinorelbine Consumption Market Share by Application (2015-2020)
Table 36. APAC Vinorelbine Consumption by Regions (2015-2020) (MT)
Table 37. APAC Vinorelbine Consumption Market Share by Regions (2015-2020)
Table 38. APAC Vinorelbine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Vinorelbine Value Market Share by Regions (2015-2020)
Table 40. APAC Vinorelbine Consumption by Type (2015-2020) (MT)
Table 41. APAC Vinorelbine Consumption Market Share by Type (2015-2020)
Table 42. APAC Vinorelbine Consumption by Application (2015-2020) (MT)
Table 43. APAC Vinorelbine Consumption Market Share by Application (2015-2020)
Table 44. Europe Vinorelbine Consumption by Countries (2015-2020) (MT)
Table 45. Europe Vinorelbine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Vinorelbine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Vinorelbine Value Market Share by Countries (2015-2020)
Table 48. Europe Vinorelbine Consumption by Type (2015-2020) (MT)
Table 49. Europe Vinorelbine Consumption Market Share by Type (2015-2020)
Table 50. Europe Vinorelbine Consumption by Application (2015-2020) (MT)
Table 51. Europe Vinorelbine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Vinorelbine Consumption by Countries (2015-2020) (MT)
Table 53. Middle East & Africa Vinorelbine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Vinorelbine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Vinorelbine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vinorelbine Consumption by Type (2015-2020) (MT)
Table 57. Middle East & Africa Vinorelbine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Vinorelbine Consumption by Application (2015-2020) (MT)
Table 59. Middle East & Africa Vinorelbine Consumption Market Share by Application (2015-2020)
Table 60. Vinorelbine Distributors List
Table 61. Vinorelbine Customer List
Table 62. Global Vinorelbine Consumption Forecast by Countries (2021-2025) (MT)
Table 63. Global Vinorelbine Consumption Market Forecast by Regions
Table 64. Global Vinorelbine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Vinorelbine Value Market Share Forecast by Regions
Table 66. Global Vinorelbine Consumption Forecast by Type (2021-2025) (MT)
Table 67. Global Vinorelbine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Vinorelbine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Vinorelbine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Vinorelbine Consumption Forecast by Application (2021-2025) (MT)
Table 71. Global Vinorelbine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Vinorelbine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Vinorelbine Value Market Share Forecast by Application (2021-2025)
Table 74. Pierre Fabre Pharmaceuticals, Inc. Product Offered
Table 75. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. Pierre Fabre Pharmaceuticals, Inc. Main Business
Table 77. Pierre Fabre Pharmaceuticals, Inc. Latest Developments
Table 78. Pierre Fabre Pharmaceuticals, Inc. Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 79. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Product Offered
Table 80. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Main Business
Table 82. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Latest Developments
Table 83. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 84. TEVA Pharms Product Offered
Table 85. TEVA Pharms Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. TEVA Pharms Main Business
Table 87. TEVA Pharms Latest Developments
Table 88. TEVA Pharms Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 89. West-Ward Pharmaceuticals Corp. Product Offered
Table 90. West-Ward Pharmaceuticals Corp. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. West-Ward Pharmaceuticals Corp. Main Business
Table 92. West-Ward Pharmaceuticals Corp. Latest Developments
Table 93. West-Ward Pharmaceuticals Corp. Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 94. Fresenius Kabi Product Offered
Table 95. Fresenius Kabi Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Fresenius Kabi Main Business
Table 97. Fresenius Kabi Latest Developments
Table 98. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 99. Hospira, Inc. Product Offered
Table 100. Hospira, Inc. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. Hospira, Inc. Main Business
Table 102. Hospira, Inc. Latest Developments
Table 103. Hospira, Inc. Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Product Offered
Table 105. Mylan Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Mylan Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 109. EBEWE Pharma (Sandoz A Novartis Division) Product Offered
Table 110. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. EBEWE Pharma (Sandoz A Novartis Division) Main Business
Table 112. EBEWE Pharma (Sandoz A Novartis Division) Latest Developments
Table 113. EBEWE Pharma (Sandoz A Novartis Division) Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 114. Dr. Reddy's Laboratories Product Offered
Table 115. Dr. Reddy's Laboratories Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 116. Dr. Reddy's Laboratories Main Business
Table 117. Dr. Reddy's Laboratories Latest Developments
Table 118. Dr. Reddy's Laboratories Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Product Offered
Table 120. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 121. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business
Table 122. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
Table 123. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Company Total Revenue (in $ million), Vinorelbine Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanxi Powerdone Pharmaceutics Co., Ltd. Product Offered
Table 125. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 126. Shanxi Powerdone Pharmaceutics Co., Ltd. Main Business
Table 127. Shanxi Powerdone Pharmaceutics Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Shanxi Powerdone Pharmaceutics Co., Ltd. Latest Developments
Table 129. Luoxin Pharmaceutical Group Co., Ltd. Product Offered
Table 130. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 131. Luoxin Pharmaceutical Group Co., Ltd. Main Business
Table 132. Luoxin Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Luoxin Pharmaceutical Group Co., Ltd. Latest Developments
Table 134. Nanjing Cuccess Pharmaceutical Co., Ltd Product Offered
Table 135. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 136. Nanjing Cuccess Pharmaceutical Co., Ltd Main Business
Table 137. Nanjing Cuccess Pharmaceutical Co., Ltd Latest Developments
Table 138. Nanjing Cuccess Pharmaceutical Co., Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Beijing SL Pharm Product Offered
Table 140. Beijing SL Pharm Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 141. Beijing SL Pharm Main Business
Table 142. Beijing SL Pharm Latest Developments
Table 143. Beijing SL Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Sinopharm A-Think Pharmaceutical Co., Ltd. Product Offered
Table 145. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 146. Sinopharm A-Think Pharmaceutical Co., Ltd. Main Business
Table 147. Sinopharm A-Think Pharmaceutical Co., Ltd. Latest Developments
Table 148. Sinopharm A-Think Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Shenzhen Main Luck Pharmaceuticals Inc. Product Offered
Table 150. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 151. Shenzhen Main Luck Pharmaceuticals Inc. Main Business
Table 152. Shenzhen Main Luck Pharmaceuticals Inc. Latest Developments
Table 153. Shenzhen Main Luck Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Qilu Pharmaceutical (Hainan) Co., Ltd. Product Offered
Table 155. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 156. Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business
Table 157. Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
Table 158. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Vinorelbine
Figure 2. Vinorelbine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vinorelbine Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Vinorelbine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral
Figure 7. Product Picture of Injection
Figure 8. Global Vinorelbine Consumption Market Share by Type (2015-2020)
Figure 9. Global Vinorelbine Value Market Share by Type (2015-2020)
Figure 10. Vinorelbine Consumed in Breast Cancer
Figure 11. Global Vinorelbine Market: Breast Cancer (2015-2020) (MT)
Figure 12. Global Vinorelbine Market: Breast Cancer (2015-2020) ($ Millions)
Figure 13. Vinorelbine Consumed in Non-small Cell Lung Cancer
Figure 14. Global Vinorelbine Market: Non-small Cell Lung Cancer (2015-2020) (MT)
Figure 15. Global Vinorelbine Market: Non-small Cell Lung Cancer (2015-2020) ($ Millions)
Figure 16. Vinorelbine Consumed in Other
Figure 17. Global Vinorelbine Market: Other (2015-2020) (MT)
Figure 18. Global Vinorelbine Market: Other (2015-2020) ($ Millions)
Figure 19. Global Vinorelbine Consumption Market Share by Application (2015-2020)
Figure 20. Global Vinorelbine Value Market Share by Application (2015-2020)
Figure 21. Global Vinorelbine Sales Market Share by Company in 2017
Figure 22. Global Vinorelbine Sales Market Share by Company in 2019
Figure 23. Global Vinorelbine Revenue Market Share by Company in 2017
Figure 24. Global Vinorelbine Revenue Market Share by Company in 2019
Figure 25. Global Vinorelbine Sale Price by Company in 2019
Figure 26. Global Vinorelbine Consumption Market Share by Regions 2015-2020
Figure 27. Global Vinorelbine Value Market Share by Regions 2015-2020
Figure 28. Americas Vinorelbine Consumption 2015-2020 (MT)
Figure 29. Americas Vinorelbine Value 2015-2020 ($ Millions)
Figure 30. APAC Vinorelbine Consumption 2015-2020 (MT)
Figure 31. APAC Vinorelbine Value 2015-2020 ($ Millions)
Figure 32. Europe Vinorelbine Consumption 2015-2020 (MT)
Figure 33. Europe Vinorelbine Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Vinorelbine Consumption 2015-2020 (MT)
Figure 35. Middle East & Africa Vinorelbine Value 2015-2020 ($ Millions)
Figure 36. Americas Vinorelbine Consumption Market Share by Countries in 2019
Figure 37. Americas Vinorelbine Value Market Share by Countries in 2019
Figure 38. Americas Vinorelbine Consumption Market Share by Type in 2019
Figure 39. Americas Vinorelbine Consumption Market Share by Application in 2019
Figure 40. United States Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 41. United States Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 43. Canada Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 45. Mexico Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Vinorelbine Consumption Market Share by Countries in 2019
Figure 47. APAC Vinorelbine Value Market Share by Regions in 2019
Figure 48. APAC Vinorelbine Consumption Market Share by Type in 2019
Figure 49. APAC Vinorelbine Consumption Market Share by Application in 2019
Figure 50. China Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 51. China Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 53. Japan Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 55. Korea Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 57. Southeast Asia Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 58. India Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 59. India Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 61. Australia Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Vinorelbine Consumption Market Share by Countries in 2019
Figure 63. Europe Vinorelbine Value Market Share by Countries in 2019
Figure 64. Europe Vinorelbine Consumption Market Share by Type in 2019
Figure 65. Europe Vinorelbine Consumption Market Share by Application in 2019
Figure 66. Germany Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 67. Germany Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 68. France Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 69. France Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 70. UK Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 71. UK Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 73. Italy Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 75. Russia Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Vinorelbine Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Vinorelbine Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Vinorelbine Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Vinorelbine Consumption Market Share by Application in 2019
Figure 80. Egypt Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 81. Egypt Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 83. South Africa Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 85. Israel Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 87. Turkey Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Vinorelbine Consumption Growth 2015-2020 (MT)
Figure 89. GCC Countries Vinorelbine Value Growth 2015-2020 ($ Millions)
Figure 90. Global Vinorelbine Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 91. Global Vinorelbine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Vinorelbine Consumption 2021-2025 (MT)
Figure 93. Americas Vinorelbine Value 2021-2025 ($ Millions)
Figure 94. APAC Vinorelbine Consumption 2021-2025 (MT)
Figure 95. APAC Vinorelbine Value 2021-2025 ($ Millions)
Figure 96. Europe Vinorelbine Consumption 2021-2025 (MT)
Figure 97. Europe Vinorelbine Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Vinorelbine Consumption 2021-2025 (MT)
Figure 99. Middle East & Africa Vinorelbine Value 2021-2025 ($ Millions)
Figure 100. United States Vinorelbine Consumption 2021-2025 (MT)
Figure 101. United States Vinorelbine Value 2021-2025 ($ Millions)
Figure 102. Canada Vinorelbine Consumption 2021-2025 (MT)
Figure 103. Canada Vinorelbine Value 2021-2025 ($ Millions)
Figure 104. Mexico Vinorelbine Consumption 2021-2025 (MT)
Figure 105. Mexico Vinorelbine Value 2021-2025 ($ Millions)
Figure 106. Brazil Vinorelbine Consumption 2021-2025 (MT)
Figure 107. Brazil Vinorelbine Value 2021-2025 ($ Millions)
Figure 108. China Vinorelbine Consumption 2021-2025 (MT)
Figure 109. China Vinorelbine Value 2021-2025 ($ Millions)
Figure 110. Japan Vinorelbine Consumption 2021-2025 (MT)
Figure 111. Japan Vinorelbine Value 2021-2025 ($ Millions)
Figure 112. Korea Vinorelbine Consumption 2021-2025 (MT)
Figure 113. Korea Vinorelbine Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Vinorelbine Consumption 2021-2025 (MT)
Figure 115. Southeast Asia Vinorelbine Value 2021-2025 ($ Millions)
Figure 116. India Vinorelbine Consumption 2021-2025 (MT)
Figure 117. India Vinorelbine Value 2021-2025 ($ Millions)
Figure 118. Australia Vinorelbine Consumption 2021-2025 (MT)
Figure 119. Australia Vinorelbine Value 2021-2025 ($ Millions)
Figure 120. Germany Vinorelbine Consumption 2021-2025 (MT)
Figure 121. Germany Vinorelbine Value 2021-2025 ($ Millions)
Figure 122. France Vinorelbine Consumption 2021-2025 (MT)
Figure 123. France Vinorelbine Value 2021-2025 ($ Millions)
Figure 124. UK Vinorelbine Consumption 2021-2025 (MT)
Figure 125. UK Vinorelbine Value 2021-2025 ($ Millions)
Figure 126. Italy Vinorelbine Consumption 2021-2025 (MT)
Figure 127. Italy Vinorelbine Value 2021-2025 ($ Millions)
Figure 128. Russia Vinorelbine Consumption 2021-2025 (MT)
Figure 129. Russia Vinorelbine Value 2021-2025 ($ Millions)
Figure 130. Spain Vinorelbine Consumption 2021-2025 (MT)
Figure 131. Spain Vinorelbine Value 2021-2025 ($ Millions)
Figure 132. Egypt Vinorelbine Consumption 2021-2025 (MT)
Figure 133. Egypt Vinorelbine Value 2021-2025 ($ Millions)
Figure 134. South Africa Vinorelbine Consumption 2021-2025 (MT)
Figure 135. South Africa Vinorelbine Value 2021-2025 ($ Millions)
Figure 136. Israel Vinorelbine Consumption 2021-2025 (MT)
Figure 137. Israel Vinorelbine Value 2021-2025 ($ Millions)
Figure 138. Turkey Vinorelbine Consumption 2021-2025 (MT)
Figure 139. Turkey Vinorelbine Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Vinorelbine Consumption 2021-2025 (MT)
Figure 141. GCC Countries Vinorelbine Value 2021-2025 ($ Millions)
Figure 142. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Market Share (2018-2020)
Figure 143. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Market Share (2018-2020)
Figure 144. TEVA Pharms Vinorelbine Market Share (2018-2020)
Figure 145. West-Ward Pharmaceuticals Corp. Vinorelbine Market Share (2018-2020)
Figure 146. Fresenius Kabi Vinorelbine Market Share (2018-2020)
Figure 147. Hospira, Inc. Vinorelbine Market Share (2018-2020)
Figure 148. Mylan Vinorelbine Market Share (2018-2020)
Figure 149. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Market Share (2018-2020)
Figure 150. Dr. Reddy's Laboratories Vinorelbine Market Share (2018-2020)
Figure 151. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Market Share (2018-2020)
Figure 152. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Market Share (2018-2020)
Figure 153. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Market Share (2018-2020)
Figure 154. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Market Share (2018-2020)
Figure 155. Beijing SL Pharm Vinorelbine Market Share (2018-2020)
Figure 156. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Market Share (2018-2020)
Figure 157. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Market Share (2018-2020)
Figure 158. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets